Physician profile
Alfredo Sy
NPI 1790059640
$865.21
in general payments reported to CMS, 2019-2025
11 companies · $33.66 in 2025
The $33.66 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $363 · 2023: $78.63 · 2024: $99.00 · 2025: $33.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.29 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $309.55 | 2021-2023 | |
| Genzyme Corporation | $128.28 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $118.05 | 2021-2024 | |
| Janssen Biotech, INC. | $94.77 | 2021-2025 | Tremfya |
| Incyte Corporation | $49.36 | 2021-2022 | |
| Pfizer INC. | $42.02 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.46 | 2022 | |
| Lilly USA, LLC | $30.17 | 2021 | |
| Amgen INC. | $22.79 | 2022 | |
| Almirall LLC | $15.10 | 2022 | |
| Galderma Laboratories, L.P. | $13.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfredo Sy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.